期刊文献+

甲状腺癌患者^(131)I治疗后唾液腺显影及损伤原因分析 被引量:6

Image and damage of salivary glands induced by ^(131)I treatment in patient with thyroid carcinoma
下载PDF
导出
摘要 目的探讨甲状腺癌患者131I治疗后唾液腺显影及损伤的原因。方法 1例甲状腺癌患者,131I全身显像唾液腺显影,对唾液腺进行SPECT/CT融合显像和超声检查。结果 SPECT/CT融合显像、唾液腺超声提示左侧慢性腮腺炎。结论甲状腺癌患者131I治疗后唾液腺显影和损伤,与唾液腺小叶导管上皮细胞膜钠碘同向转运体摄取131I,131I发射β射线使细胞发生坏死有关,要密切观察及监测唾液腺功能。 Objectivet To evaluate the image and damage of salivary gland induced by 1311 treatment in patient with thyroid carcinoma. Methods One case of thyroid cancer, for left salivary gland developing in 131I whole body imaging, were examined SPECT/CT fusion imaging and ultrasound of salivary glands. Results Left chronic parotitis was proved by fusion imaging and ultrasound. Conclusion 131I used to treat thyroid cancer patient is taken up by the salivary glands for sodium iodine symporter. β-radiation from 131I exerts cytotoxic effects in the salivary glands.
作者 赵祯 贾莉
出处 《西部医学》 2013年第2期274-275,共2页 Medical Journal of West China
基金 国家自然科学基金资助项目(81201118)
关键词 唾液腺 放射性碘治疗 甲状腺癌 Salivary glands Radioiodine Thyroid cancer
  • 相关文献

参考文献9

二级参考文献46

  • 1陈立波,罗全勇,余永利,金常青,于建芳,陆汉魁,朱瑞森,沈艳.分化型甲状腺癌患者的^(131)I-SPECT/CT断层融合显像[J].中国医学影像技术,2004,20(7):1111-1113. 被引量:11
  • 2川玲,赵文锐,朱家瑞,许根祥,王新强,高春华,方庭正.分化型甲状腺癌^(131)I治疗后SPECT/CT融合显像的临床研究[J].中国医学影像技术,2006,22(9):1412-1414. 被引量:14
  • 3左书耀,咸雨蔚.^(131)I-SPECT/CT与^(131)I-WBI对分化型甲状腺癌转移灶的诊断价值比较[J].青岛大学医学院学报,2007,43(2):100-101. 被引量:3
  • 4张晓明,冯珏,张文军,董慧兰,赵丽红,郭玉环,赵世静,何荣喜.核素唾液腺动态显像定量分析评价干燥综合征唾液腺功能的研究[J].中国医学影像技术,2007,23(4):608-612. 被引量:18
  • 5Mendoza A, Shaffer B, Karakla D, et al. Quality of life with well-differentiated thyroid cancer: treatment toxicitices and their reduction[J]. Thyroid, 2004, 14: 133-140.
  • 6He B, Wahl RL, Du Y, et al. Comparison of residence time estimation methods for radioimmunotherapy dosimetry and treatment planning-Monte Carlo simulation studies [J]. IEEE Trans Med Imag, 2008, 4: 521-530.
  • 7Jentzen W, Schneider E, Freudenberg L, et al. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer [J]. Nucl Med Commu, 2006, 27: 669-676.
  • 8Postema E J, Borjesson PKE, Buijs WCAM, et al. Dosimetric analysis of radioimmunotherapy with Re-186-1abeled bivatuzumab in patients with head and neck cancer[J]. J Nucl Med, 2003, 44: 1690-1699.
  • 9Stabin M, Sparks RB, Crowe E. OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine[J]. J Nucl Med, 2005, 46: 1023-1027.
  • 10Grosev D, Loncaric S, Huic D, et al. Geometric models in dosimetry of thyroid remnnant mass[J]. Nuklearmedizin, 2008, 47: 120-126.

共引文献30

同被引文献49

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部